Targeting CD73 with AB680 (Quemliclustat), a Novel and Potent Small-Molecule CD73 Inhibitor, Restores Immune Functionality and Facilitates Antitumor Immunity
Piovesan, Dana, Tan, Joanne B L, Becker, Annette, Banuelos, Jesus, Narasappa, Nell, DiRenzo, Daniel, Zhang, Kristen, Chen, Ada, Ginn, Elaine, Udyavar, Akshata R, Yin, Fangfang, Paprcka, Susan L, Purandare, Bhamini, Park, Timothy W, Kimura, Nikki, Kalisiak, Jaroslaw, Young, Stephen W, Powers, Jay P, Schindler, Uli, Sivick, Kelsey E, Walters, Matthew J
Published in Molecular cancer therapeutics (01.06.2022)
Published in Molecular cancer therapeutics (01.06.2022)
Get full text
Journal Article
Molecular Evidence for an Extreme Genetic Bottleneck During Introduction of an Invading Grass to California
Meimberg, Harald, Hammond, John I., Jorgensen, Chad M., Park, Timothy W., Gerlach, John D., Rice, Kevin J., McKay, John K.
Published in Biological invasions (01.09.2006)
Published in Biological invasions (01.09.2006)
Get full text
Journal Article
Abstract 3862: AB474, a potent orally bioavailable inhibitor of arginase, for the treatment of cancer
Eckard, Sterling C., Chen, Yu, Piovesan, Dana, Narasappa, Nell, Park, Timothy W., Kalisiak, Jarek, Newcomb, Eric T., Leleti, Manmohan R., Soni, Divyank, Ginn, Elaine, Chen, Jie, DiRenzo, Dan, Zhang, Kristen, Jin, Lixia, Young, Stephen W., Walters, Matthew J., Schindler, Ulrike, Powers, Jay P.
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Get full text
Journal Article